week 2 Flashcards

(73 cards)

1
Q

what growth measures are routinely collected in UK children

A

weight - baby, school age and sometimes pre school age
head circumference - only as a baby
length - only as a baby and if they cannot stand
height - after age 2
BMI - after age 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is weight measured

A

using clincal grade electronic scales
wearing light indoor clothes and no shoes
babies weighed naked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how is head circumference measured

A

using a non-elastic plastic tape

measured 3 times or more - until at least 2 are the same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how is length measured

A

using a stiff or rigid board

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how is height measured

A

using rigid measure with t piece or stadiometer

shoes off, feet flat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does it mean if a patient is outside +2SD or -2SD on a growth chart

A

not healthy at all

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

standard centile lines

A

lines on the growth chart are evenly spaced at 2/3 SD and include extreme outer centiles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what does a height on the 25th centile mean

A

should be around 25 children shorter and 75 taller

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how did WHO build an ideal growth chart

A

6 different cohorts from around the world using the same protocol and criteria:
child healthy
breastfed for first 4 months and impartially for a year
no smoking
prosperous mothers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how to tell if an individuals growth is normal

A

both weight and height tend to track within one centile space
weight commonly varies over short term in pre school years due to illness
height may show wide variation due to measurement error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what makes a child short

A
genetic - polygenic inheritance 
rate of maturation - some grow faster than others
severe chronic illness and treatment
chromosomal anomolies: turners, downs
growth hormone deficiency 
chronic undernutrition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the 3 severities of malnutrition

A

severe acute malnutrition - below 3 standard deviations of median weight or height, visible severe wasting or presence of nutritional oedema
moderate malnutrition - weight loss and 2 to 3 SDs below the median weight or height
acute malnutrition - 1 to 2 SDs below median weight or height

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 types of malnutrition

A

mineral deficiency
protein energy malnutrion
avitaminosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

BMI for an obese adult

A

> 30 for obesity

>25 for overweight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what medical problems is obesity associated with

A
type II diabetes
ischaemic heart disease
cerebrovascular disease
osteoarthritis 
hypertension 
some cancers
psychological problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

social problems associated with obesity

A

body image dichotomy
difficulty engaging in some common social activities eg gym or employment
stigma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

economic problems associated with obesity

A

sick leave

costs to NHS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

causes of obesity

A
genetic predispositions
leptin and appetite control
insulin production and fat deposition
individual diet and exercise patterns
deprivation, learning disability, gender and race
obesogenic environment
technological progress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is an obesogenic environment

A

readily available, cheap and heavily marketed energy rich foods
increase in labour saving devices eg lifts
increase in passive and motorised personal transport eg cars instead of walking
decreased participation i nactive leisure pursuits and total energy expenditure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

milk-producing cells

A

lactocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

function of oxytocin in breastmilk

A

stimulates myoepithelial cells to contract, pushing the milk into lactiferous ducts and towards the nipple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

function of montgomery tubercles

A

glands which secrete a sebaceous fluid that lubricates the nipple and protects the skin
fluid has an individual aroma attracting infant to the mother

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

control of lactation

A

suckling sends powerful stimulus via higher sensors in the hypothalamus to posterior pituitary - secretes oxytocin
this acts on smooth muscle in alveoli which contract and inject milk into the lactiferous ducts
same stimulus acts on anterior pituitary to produce lactin - stimulates lactocytes to secrete milk for the next feed
milk contains feedback inhibitor of lactation which inhibits milk production when it accumulates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

protein in human milk

A

main one is alpha lactalbumin and is associated with the destruction of over 40 types of cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
carbohydrate in milk
Lactose is the main primary carbohydrate - provides 40% of total calories improves the absorption of calcium and promotes growth of healthy bacteria
26
components of human milk not in formula
``` stem cells growth factors immunoglobulins leukocytes lactoferrin oligosaccharides human milk lipids IL-7 ```
27
describe colostrum
``` first milk produced from breasts from 16 weeks of pregnancy consists of thick, yellowish fluid rich in vit A antibodies and anti-infective proteins ```
28
benefits of breastfeeding
immune protection: breastfeeding activates broncho-entero-mammary pathway - when mother inhales pathogens, lymph nodes in the lungs and small intestine manufacture specially sensitised lymphocytes which migrate to the breasts and create antibodies promotes development of the brain: contains long-chain polyunsaturated fatty acids such as docosahexaenoic which support brain development and intelligence promotes maturation of gut: epidermal GF promotes healing, neuronal GFs promote development of peristalsis - help reduce chance of necrotising enterocolitis protects mothers health: protects against postpartum haemorrhage and depression, ovarian and breast cancers, heart disease and type II diabetes
29
importance of skin to skin contact
triggers lactation and mothering hormones triggers calming hormones in the baby stimulates digestion stimulates instinctive feeding behaviors enables infants skin to become colonised by protective bacteria from mothers skin
30
positioning during breastfeeding
``` CHIN keep baby Close baby will tilt Head back baby's head and body should be In line Nose to nipple ```
31
role of oxytocin in babies
when they feel secure they release oxytocin | vital for brain development
32
doctors role in breastfeeding
encourage and discuss importance encourage skin to skin contact acknowledge mother may need support avoid advising supplementary bottle feeds just to allay anxiety dont prescribe medication without checking safety for lactation
33
breastfeeding as a societal issue
breasts still seen as sexual little support for breast feeding in public or long-term breastfeeding media portrays bottle feeding
34
breastfeeding as an economical issue
not breastfeeding is associated with lower intelligence and economic losses failing to breastfeed costs global economy
35
aim of an immunisation programme
to protect those at highest risk (selective immunisation stategy) or to eradicate, eliminate or contain disesae (mass immunisation strategy)
36
describe selective vaccination
``` vaccine does not need to be given to all, only those at increased risk of disease: travel high risk groups occupational risk outbreak control ```
37
describe mass vaccination
eradication - disease and causal agent removed worldwide elimination - disease disappeared from one WHO region but remains elsewhere containment - disease no longer constitutes a significatn public health problem
38
aim of an ideal vaccine
to produce the same immune protection which usually follows natural disease but without causing the disease to generate long-lasting immunity to interrupt spread of infection
39
contradictions and precautions of vaccinations
those with primary or acquired immunodefiency those on immunosuppressives, including biological therapy pregnant women infants born to a mother who received immunosuppressive biological therapy during pregnancy those in contact with an individual with immunodeficiency, current recent immunosuppressive including biological therapy
40
what are live vaccines
attenuated (weakened) strains which replicate in host act like natural infection closest to actual infection and therefore elicit good, strong, long-lasting immune responses
41
examples of live vaccines
MMR BCG yellow fever
42
what are inactivated vaccines
do not contain a pathogen capable of replicating and causing disease
43
live v inactivated vaccines
``` live: longer lasting immunity strong immune response evoked can revert to virulence poor stability cannot use in pregnancy or immunosupressed inactivated: shorter lasting immunity adjuvant needed unable to cause infection stable constituents clearly defined less contradictions need several doses local reactions common ```
44
describe herd immunity
for. each disease there is a certain level of immunity in the population which protects the whole population because the pathogen stops spreading within the community provides indirect protection of unvaccinated individuals
45
examples of vaccine preventable diseases
``` bacterial: diphtheria tetanus TB pertussis (whooping cough) meningococcal c disease pneumococcal disease viral: measles mumps rubella HPV varicella Hep b influenza poliomyelitis ```
46
what is passive immunity
provides protection at, or around the time of exposure to a specific pathogen given to individuals who are at high risk of severe disease or of developing severe complications from the disease they provide immediate but temporary protection does no stimulate the immune system to make any antibodies
47
example of passive immunity
transplacental - most important source in newborn
48
types of antibody preparations
human source - pooled blood preparations from donors (plasma or immunoglobulin) monoclonal animal source
49
examples of antibodie preparations from human sources
hepatitis b immunoglobulin human rabies immunoglobulin tetanus immunoglobulin
50
antibody preparation pros and cons
pros: rapid, preventative, can be given to those where vaccine is contradicted cons: expensive, potential for adverse events, limited evidence base for some, no lasting immunity
51
factors influencing a vaccine
``` benefit to others fidelity (keep commitments) autonomy no harm transparency (reasons behind) justice utility (helping great amount of people) trust privacy (sharing of data) risk effectiveness reciprocity (taking vaccine when healthy - some become unhealthy) ```
52
questions to consider when developing a vaccine programme
is there a need for the vaccine? - does it cause a significant health problem is a suitable vaccine available that is safe and effective? can the programme be delivered in a safe, effective and cost-effective manner? what is the aim of the programme?
53
what is surveillance of a vaccine programme
the ongoing, systematic collection, recording, analysis, interpretation and disseminaton of data
54
when does surveillance of a vaccine programme need to occur
``` pre-implementation: to estimate burden of disease to decide vaccine strategy post implementation: to monitor effectiveness of vaccine strategy ```
55
issues in vaccine policy decisions
``` disease incidence, vaccine safety, efficacy from surveillance aim of programme cost of programme population accessibility cultural attitudes and practices facilities available for delivery ```
56
symptoms of pertussis
``` initially: cold-like symptoms followed by: gradually worsening cough paroxysms of coughing characteristic whoop post-tussive vomiting conjuctival haemorrhage ```
57
complications of pertussis
respiratoy - majority of cases involve a collapsed lung and/or pneumonia neurological - lack of oxygen leading to altered consciousness, convulsions, permanent brain damage, death severe weight loss and dehydration due to vomiting sudden death
58
history of pertussis vaccines
whole cell vaccine used until 2004 rates dropped to 30% in 1975 due to anxiety about safety epidemics between 1977 and 1983 acellular vaccine added to preschool booster in 2001 and replaced whole cell vaccine in 2004
59
current issues with pertussis
some evidence of vaccine waning with age pertussis remains the most common vaccine preventable disease in <1y with highest mortality 2012 temporary programme to offer vaccine to pregnant women weeks 28 and 32 - 2014 programme extended for at least 5 years 2016 advice changed so vaccine given from week 16
60
challenges of global immunisation
``` funding, coverage, uptae surveillance different priorities, different vaccines multiple agencies: bill and melinda gates, UNICEF suspicion, mistrust violence - war, civil unrest ```
61
difference between active immunity and passive immunity
active - protection produced by a persons own immune system by natural infection or artificial immunisation means passive - protection transferred from another person or animal as antibody. can be natural (transplacental) or artifical (immunoglobulin)
62
vaccine definition
induced immunity using vaccine
63
immunisation definition
vaccine induced immunity and the transfer of antibodies/immunoglobulins
64
antigen definition
a live or inactivated substance capable of producing an immune response or any substance than be bound by an antibody
65
antibody definition
immunoglobulin produced by b lymphocytes to help eliminate a pathogen
66
polysaccharide v conjugate vaccines
polysaccharide: t-cell independent less immunogenic in under 2s no booster response - immune response after 2nd dose is similar to 1st dose conjugate: polysaccharide antigen linked to a protein antigen (strong anitgen with weak antigen - strong immune response to weak antigen) conjugates can include toxoids, CRM197 designed to enhance immune response, particularly in children under 2y/o
67
components of a vaccine
stabilisers - prevent components adhering to side of vial trace components preservatives antibiotics adjuvants - substance that enhances immune response in presence of an antigen
68
purpose of intervals between vaccines
to allow each immune response to develop | to avoid immune interference
69
primary v secondary vaccine failure
primary - no/limited response | secondary - immunity wanes over time
70
frequency of adverse events in live and inactivated vaccines
live - reduces with additional dose | inactive - increases with additional dose
71
timing of adverse events in live and inactivated vaccines
live - depends on time for pathogen to replicate | inactive - generally within 48 hours of vaccine
72
what is the reproduction number
r = the effective reproduction number number of secondary infections produced by a typical infective r0 = basic reproduction number number of secondary infections produced by a typical infective in a totally susceptible population R0>1 = epidemic possible
73
herd immunity threshold
HIT = 1 - (1/R0) how many people we need to vaccinate to prevent epidemic also called critical vaccine threshold